Veritas Pharma Inc. (CNSX:VRT), an emerging discovery and IP development company, has announced that it has placed its final payment of $250,000 to Cannevert Therapeutics Ltd. (CTL) (scheduled for May ...
Veritas Pharma Inc. (VRT: CNX) has completed its second to last payment of $250,000 to Cannevert Therapeutics Ltd. (CTL). This latest installment brings Veritas’s total investment in CTL to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results